Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma

Endocrine-Related Cancer

Volumn 16, Issue 2, 2009, Pages 491-503

  Akulevich, Natallia M ^a   Saenko, Vladmir A ^a   Rogounovitch, Tatiana I ^a   Drozd, Valentina M ^b   Lushnikov, Eugeny F ^c   Ivanov, Victor K ^c   Mitsutake, Norisato ^a   Kominami, Ryo ^d   Yamashita, Shunichi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b BELARUSIAN MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Belarus)

^c MEDICAL RADIOLOGICAL RESEARCH CENTER   (Russian Federation)

^d NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ARGININE; ATM PROTEIN; CYTOSINE; GENOMIC DNA; GLUTAMINE; GUANINE; METAL RESPONSIVE TRANSCRIPTION FACTOR 1; PROLINE; PROTEIN P53; THYMINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; XRCC1 PROTEIN; XRCC3 PROTEIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; TP53 PROTEIN, HUMAN; TRANSCRIPTION FACTOR MTF 1; TRANSCRIPTION FACTOR MTF-1; TUMOR SUPPRESSOR PROTEIN; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 3;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CAUCASIAN; CHERNOBYL ACCIDENT; CONTROLLED STUDY; DNA DAMAGE; DNA POLYMORPHISM; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; RADIATION INJURY; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID PAPILLARY CARCINOMA; AGED; CASE CONTROL STUDY; COMPARATIVE STUDY; DNA REPAIR; GENETIC MARKER; GENETICS; IONIZING RADIATION; MIDDLE AGED; PAPILLARY CARCINOMA; PHENOTYPE; RETROSPECTIVE STUDY; RISK FACTOR; THYROID TUMOR;

ADULT; AGED; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENETIC MARKERS; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RADIATION, IONIZING; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 67650468322     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-08-0336     Document Type: Article

References (49)

1. Alsbeih G, El-Sebaie M, Al-Harbi N, Al-Buhairi M, Al-Hadyan K & Al-Rajhi N 2007 Radiosensitivity of human fibroblasts is associated with amino acid substitution variants in susceptible genes and correlates with the number of risk alleles. International Journal of Radiation Oncology, Biology, Physics 68 229-235.
2. Angele S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gerard JP et al. 2003 ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Research 63 8717-8725.
3. Bennett B, Repacholi M & Carr Z 2006 Health Effects of the Chernobyl Accident and Special Health Care Programmes. Geneva: WHO Press.
4. Boltze C, Roessner A, Landt O, Szibor R, Peters B & Schneider-Stock R 2002 Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma. International Journal of Oncology 21 1151-1154.
5. Bouville A, Likhtarev IA, Kovgan L, Minenko VF, Shinkarev SM & Drozdovitch V 2007 Radiation dosimetry for highly contaminated Belarusian, Russian and Ukranian populations, and for less contaminated populations in Europe. Health Physics 93 487-501.
6. 131I in childhood. Journal of the National Cancer Institute 97 724-732.
7. Davies L & Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. Journal of the American Medical Association 295 2164-2167.
8. Davis S, Stepanenko V, Rivkind N, Kopecky KJ, Voilleque P, Shakhtarin V, Parshkov E, Kulikov S, Lushnikov E, Abrosimov A et al. 2004 Risk of thyroid cancer in the Bryansk oblast of the Russian Federation after the Chernobyl Power Station accident. Radiation Research 162 241-248.
9. Detours V, Delys L, Libert F, Weiss Solis D, Bogdanova T, Dumont JE, Franc B, Thomas G & Maenhaut C 2007 Genome-wide gene expression profiling suggests distinct radiation susceptibility in sporadic and post-Chernobyl papillary thyroid cancers. British Journal of Cancer 97 818-825.
10. Detours V, Versteyhe S, Dumont JE & Maenhaut C 2008 Gene expression profiles of post-Chernobyl thyroid cancers. Current Opinion in Endocrinology, Diabetes, and Obesity 15 440-445.
11. Duell EJ, Millikan RC, Pittman GS, Winkel S, Lunn RM, Tse CK, Eaton A, Mohrenweiser HW, Newman B & Bell DA 2001 Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiology, Biomarkers & Prevention 10 217-222.
12. Edvardsen H, Tefre T, Jansen L, Vu P, Haffty BG, Fossa SD, Kristensen VN & Borresen-Dale AL 2007 Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence. Radiation Oncology 2 25.
13. Figueiredo JC, Knight JA, Briollais L, Andrulis IL & Ozcelik H 2004 Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiology, Biomarkers & Prevention 13 583-591.
14. Granja F, Morari J, Morari EC, Correa LA, Assumpcao LV & Ward LS 2004 Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Letters 210 151-157.
15. Hall EJ, Schiff PB, Hanks GE, Brenner DJ, Russo J, Chen J, Sawant SG & Pandita TK 1998 A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. Cancer Journal from Scientific American 4 385-389.
16. Han S, Zhang HT, Wang Z, Xie Y, Tang R, Mao Y & Li Y 2006 DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies. European Journal of Human Genetics 14 1136-1144.
17. Heikkinen K, Rapakko K, Karppinen SM, Erkko H, Nieminen P & Winqvist R 2005 Association of common ATM polymorphism with bilateral breast cancer. International Journal of Cancer 116 69-72.
18. Hillebrandt S, Streffer C, Demidchik EP, Biko J & Reiners C 1997 Polymorphisms in the p53 gene in thyroid tumours and blood samples of children from areas in Belarus. Mutation Research 381 201-207.
19. Hoeijmakers JH 2001 Genome maintenance mechanisms for preventing cancer. Nature 411 366-374.
20. Hosking L, Lumsden S, Lewis K, Yeo A, McCarthy L, Bansal A, Riley J, Purvis I & Xu CF 2004 Detection of genotyping errors by Hardy-Weinberg equilibrium testing. European Journal of Human Genetics 12 395-399.
21. Hu JJ, Smith TR, Miller MS, Lohman K & Case LD 2002 Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environmental and Molecular Mutagenesis 39 208-215.
22. Hu Z, Ma H, Chen F, Wei Q & Shen H 2005 XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiology, Biomarkers & Prevention 14 1810-1818.
23. Jacob P, Bogdanova TI, Buglova E, Chepurniy M, Demidchik Y, Gavrilin Y, Kenigsberg J, Meckbach R, Schotola C, Shinkarev S et al. 2006 Thyroid cancer risk in areas of Ukraine and Belarus affected by the Chernobyl accident. Radiation Research 165 1-8.
24. Khanna KK & Jackson SP 2001 DNA double-strand breaks: signaling, repair and the cancer connection. Nature Genetics 27 247-254.
25. Khrunin AV, Tarskaia LA, Spitsyn VA, Lylova OI, Bebyakova NA, Mikulich AI & Limborska SA 2005 p53 polymorphisms in Russia and Belarus: correlation of the 2-1-1 haplotype frequency with longitude. Molecular Genetics and Genomics 272 666-672.
26. Likhtarev I, Bouville A, Kovgan L, Luckyanov N, Voilleque P & Chepurny M 2006 Questionnaire- and measurement-based individual thyroid doses in Ukraine resulting from the Chornobyl nuclear reactor accident. Radiation Research 166 271-286.
27. Malmer BS, Feychting M, Lonn S, Lindstrom S, Gronberg H, Ahlbom A, Schwartzbaum J, Auvinen A, Collatz-Christensen H, Johansen C et al. 2007 Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma. Journal of Neuro-oncology 82 229-237.
28. Nikiforov YE, Nikiforova MN, Gnepp DR & Fagin JA 1996 Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident. Oncogene 13 687-693.
29. Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H & Fagin JA 1997 Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Research 57 1690-1694.
30. Pietsch EC, Humbey O & Murphy ME 2006 Polymorphisms in the p53 pathway. Oncogene 25 1602-1611.
31. Pim D & Banks L 2004 p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. International Journal of Cancer 108 196-199.
32. Rabes HM, Demidchik EP, Sidorow JD, Lengfelder E, Beimfohr C, Hoelzel D & Klugbauer S 2000 Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-Chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. Clinical Cancer Research 6 1093-1103.
33. Rogounovitch TI, Saenko VA, Ashizawa K, Sedliarou IA, Namba H, Abrosimov AY, Lushnikov EF, Roumiantsev PO, Konova MV, Petoukhova NS et al. 2006 TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer. Oncology Reports 15 949-956.
34. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA & Boice JD Jr 1995 Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiation Research 141 259-277.
35. Rothman KJ & Greenland S 1998 Modern Epidemiology. 2nd edn. Philadelphia: Lipincott-Raven.
36. Shiloh Y 2003 ATM and related protein kinases: safeguarding genome integrity. Nature Reviews. Cancer 3 155-168.
37. Siddique MM, Barlam C, Fiszer-Maliszewska L, Aggarwal A, Tan A, Tan P, Soo KC & Sabapathy K 2005 Evidence for selective expression of the p53 codon 72 polymorphs: implications in cancer development. Cancer Epidemiology, Biomarkers & Prevention 14 2245-2252.
38. Soussi T & Wiman KG 2007 Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell 12 303-312.
39. Stepanenko VF, Voilleque PG, Gavrilin YuI, Khrouch VT, Shinkarev SM, Orlov MYu, Kondrashov AE, Petin DV, Iaskova EK & Tsyb AF 2004 Estimating individual thyroid doses for a case-control study of childhood thyroid cancer in Bryansk oblast, Russia. Radiation Protection Dosimetry 108 143-160.
40. Sturgis EM, Zhao C, Zheng R & Wei Q 2005 Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis. Laryngoscope 115 938-945.
41. Tamura Y, Maruyama M, Mishima Y, Fujisawa H, Obata M, Kodama Y, Yoshikai Y, Aoyagi Y, Niwa O, Schaffner W et al. 2005 Predisposition to mouse thymic lymphomas in response to ionizing radiation depends on variant alleles encoding metal-responsive transcription factor-1 (Mtf-1). Oncogene 24 399-406.
42. Taylor RM, Thistlethwaite A & Caldecott KW 2002 Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair. Molecular and Cellular Biology 22 2556-2563.
43. Thorstenson YR, Roxas A, Kroiss R, Jenkins MA, Yu KM, Bachrich T, Muht D, Wayne TL, Chu G, Davis RW et al. 2003 Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Research 63 3325-3333.
44. m-shift primers. BioTechniques 39 885-893.
45. Williams ED 2006 Chernobyl and thyroid cancer. Journal of Surgical Oncology 94 670-677.
46. Yamashita S & Saenko V 2006 Mechanisms of disease: molecular genetics of childhood thyroid cancers. Nature Clinical Practice. Endocrinology & Metabolism 3 422-429.
47. Yang T, Namba H, Hara T, Takamura N, Nagayama Y, Fukata S, Ishikawa N, Kuma K, Ito K & Yamashita S 1997 p53 induced by ionizing radiation mediates DNA end-jointing activity, but not apoptosis of thyroid cells. Oncogene 14 1511-1519.
48. Yen CY, Liu SY, Chen CH, Tseng HF, Chuang LY, Yang CH, Lin YC, Wen CH, Chiang WF, Ho CH et al. 2008 Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. Journal of Oral Pathology & Medicine 37 271-277.
49. Yoon YJ, Chang HY, Ahn SH, Kim JK, Park YK, Kang DR, Park JY, Myoung SM, Kim do Y, Chon CY et al. 2008 MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Carcinogenesis 29 1192-1196.